Febuxostat

compare suppliers & send inquiries for free

Looking for Febuxostat 144060-53-7?

Description:

Here you will find a list of producers, manufacturers and traders of Febuxostat. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.

API | Excipient name:

Febuxostat 

Synonyms:

Febuxostat , Febuxostat , Febuxostatum  

Cas Number:

144060-53-7 

DrugBank number:

DB04854 

Unique Ingredient Identifier:

101V0R1N2E

Febuxostat is a type of Uric acid lowering agents

Uric acid lowering agents are a subcategory of pharmaceutical active pharmaceutical ingredients (APIs) specifically designed to target and reduce elevated levels of uric acid in the body. Uric acid is a byproduct of purine metabolism and is typically excreted through the kidneys. However, when uric acid levels become excessively high, it can lead to a condition known as hyperuricemia, which is associated with gout and other related disorders.

Uric acid lowering agents work by inhibiting the production of uric acid or enhancing its excretion from the body. One commonly used class of drugs in this category is xanthine oxidase inhibitors (XOIs), which inhibit the enzyme xanthine oxidase responsible for converting purines to uric acid. By reducing the activity of xanthine oxidase, XOIs effectively lower uric acid levels.

Another class of drugs used as uric acid lowering agents are uricosurics. Uricosurics work by blocking the reabsorption of uric acid in the kidneys, thereby increasing its elimination through urine. This mechanism helps to lower the concentration of uric acid in the bloodstream.

Uric acid lowering agents play a crucial role in the management of hyperuricemia and related conditions such as gout. By effectively reducing uric acid levels, these pharmaceutical APIs alleviate symptoms associated with elevated uric acid, such as joint pain and inflammation.

It is important to note that the use of uric acid lowering agents should be done under the guidance and supervision of a healthcare professional. Individual patient factors and medical history should be considered when determining the appropriate medication and dosage.

Febuxostat (Uric acid lowering agents), classified under Genitourinary Agents

Genitourinary agents are a category of pharmaceutical active ingredients (APIs) that are specifically designed to target and treat disorders related to the genitourinary system. The genitourinary system encompasses the organs and structures involved in the production, storage, and elimination of urine, as well as the reproductive organs.

These APIs play a crucial role in the treatment of various genitourinary conditions, including urinary tract infections (UTIs), erectile dysfunction, urinary incontinence, benign prostatic hyperplasia (BPH), and other related disorders. They exert their therapeutic effects by interacting with specific receptors or enzymes in the genitourinary system, regulating physiological processes, and restoring normal function.

Some commonly used genitourinary agents include alpha-blockers, which relax the smooth muscles in the prostate and bladder neck, improving urine flow in patients with BPH. Additionally, phosphodiesterase type 5 inhibitors (PDE5 inhibitors) are widely prescribed for erectile dysfunction, as they enhance blood flow to the penile tissues, facilitating erection.

These APIs are typically formulated into various dosage forms, such as tablets, capsules, creams, gels, or injections, allowing for convenient administration to patients. The development and production of genitourinary agents involve stringent quality control measures and compliance with regulatory guidelines to ensure safety, efficacy, and consistent product performance.

In summary, genitourinary agents form a crucial category of pharmaceutical APIs used to treat a range of disorders affecting the genitourinary system. Their targeted mechanisms of action and diverse dosage forms make them valuable tools in improving genitourinary health and enhancing patients' quality of life.

• LGM Pharma from United States
• Curia from United States
• Vasudha Pharma Chem Ltd. from India
• Apino Pharma Co., Ltd. from China
• TIEFENBACHER API + Ingredients from Germany
• Unimark Remedies from India
• Lupin from India
• Excel Industries from India
• Indoco Remedies from India
• Cadila Healthcare from India
• Fabbrica Italiana Sintetici (FIS) from Italy
• Chongqing Shenghuaxi from China
• NGL Fine Chem from India
• Teva API from Israel
• WANBANG BIOPHARMA from China
• Beijing Lunarsun Pharma from China
• Quimica Sintetica from Spain
• HEC Pharm from Germany
• Utopharm (Shanghai) Company Limited from China
• Unnati Pharmaceuticals Pvt Ltd from India
• Dalian Wista Pharma Co Ltd from China
• PLIVA from Czech Republic
• Signa from Mexico
• Aurobindo from India
• Sun Pharma from India
• Alembic Pharma from India
• Emcure Pharma from India
• MSN Organics from India
• Jubilant Generics from India
• Jiangxi Synergy from China
• Mylan from India
• Duke Chem from Spain

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.